Some reports showed that the genetic mutation of some important genes, including TP53, CTNNB1, and AXIN1, was relevant to poor outcomes for patients with HCC (Zhan et al., 2013; Schulze et al., 2015). Here, AXIN1 is linked to hepatocellular carcinoma.